Skip to content

Psychological and Clinical Outcomes of Splint Therapy with and Without Doctor-Patient Communication in TMD Management

Psychological and Clinical Outcomes After Splint Therapy with Versus Without Doctor-patient Communication Concept in the Management of TMDs

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06783530
Acronym
TMD
Enrollment
435
Registered
2025-01-20
Start date
2023-07-01
Completion date
2024-10-30
Last updated
2025-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Disorders (TMDs)

Keywords

Splint Therapy, Doctor-Patient Communication, Non-Surgical TMD Treatment, TMDs management

Brief summary

This study aimed to evaluate the psychological and clinical outcomes of patients undergoing splint therapy with or without enhanced doctor-patient communication in the management of temporomandibular disorders (TMDs). The study compared treatment approaches to determine their impact on patient satisfaction and clinical results.

Detailed description

Temporomandibular disorders (TMDs) are prevalent conditions characterized by jaw pain, functional limitations, and psychological distress. This study investigated the impact of splint therapy combined with enhanced doctor-patient communication on psychological well-being and clinical outcomes. Participants were randomly assigned to receive standard splint therapy or splint therapy with additional doctor-patient communication strategies. The primary outcomes include clinical and psychological status improvements, measured over six months, and patient satisfaction, assessed over a one-year period. The results aimed to provide insights into optimizing treatment strategies for TMD patients.

Interventions

BEHAVIORALSplint Therapy with Enhanced Doctor-Patient Communication

A structured communication protocol aimed at improving doctor-patient interaction and treatment adherence.

A custom-fitted occlusal splint designed to alleviate symptoms of temporomandibular disorders (TMD).

Sponsors

Soaad Tolba Mohammed Tolba Badawi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The allocation was concealed from participants and the statistician performing the data analysis to minimize bias. However, the clinician administering the intervention was aware of the patient's allocation to ensure appropriate treatment delivery.

Intervention model description

This study used a parallel assignment model with two groups: one receiving standard splint therapy and the other receiving splint therapy with enhanced doctor-patient communication.

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients complaining of pain in the orofacial region (either arthrogenous and/or myogenous TMD) in the last 3 months, who never underwent any type of treatment for TMD's. * Age ≥16 years.

Exclusion criteria

* patients who have already undergone any treatment for TMD's, edentulous patients, * patients with any systemic disease that could cause joint and/or muscle changes, * patients who were undergoing drug treatment for the condition, current pregnancy, or breastfeeding.

Design outcomes

Primary

MeasureTime frameDescription
Change in Depression, Anxiety, and Stress levelsBaseline to 6 months.Depression, anxiety, and stress levels was measured using the 10-item Depression, Anxiety, and Stress Scale (DASS-10) at baseline and after six months of therapy. The DASS-10 comprises 10 items, each rated on a 4-point Likert scale ranging from 0 (Did not apply to me at all) to 3 (Applied to me very much or most of the time). * Minimum value: 0 * Maximum value: 30 * Interpretation: Higher scores indicate worse psychological outcomes.
Change in Interincisal Mouth OpeningBaseline to 6 months.Maximum interincisal mouth opening was measured at baseline and after six months of therapy using a calibrated caliper.
Change in Intra-articular pain (IAP)Baseline to 6 months.Intra-articular pain was assessed at baseline and after six months using the Visual Analog Scale (VAS) for pain intensity. The scale ranged from 0 to 10, where: * Minimum value: 0 (No pain) * Maximum value: 10 (Worst possible pain).
Change in Joint Sound Presence and CharacteristicsBaseline to 6 months.Joint Sounds were measured in scores from 0 to 5, where 0 = no joint sound, 1 = Joint noise on occasion, 2 = palpable clicking, 3 = audible clicking, 4 = absence of previous clicking (closed lock), and 5 = crepitation. Assessment of the presence and characteristics of joint sounds was performed at baseline and after six months of therapy.

Secondary

MeasureTime frameDescription
Change in Masticatory Muscle Pain IntensityBaseline to 6 months.Pain intensity in the masticatory muscles (e.g., masseter, temporalis, medial pterygoid, lateral pterygoid) was assessed by palpation at specific points, which uses a pain scale from zero to three (0: pressure only; 1: mild pain; 2: moderate pain; 3: severe pain). Pain assisted by palpation pressure (1kg pressure for 5sec) as defined in DC/TMD.
Patient Satisfaction with TreatmentFrom 6 months to 1-year post-intervention.Each patient was evaluated at 6 and 12 months after intervention. The patient satisfaction questionnaire comprised two questions assessed using a 10-point Likert scale (1 = extremely dissatisfied to 10 = perfect/strongly satisfied). * Overall satisfaction with the clinical result of the treatment. * Satisfaction with the fulfillment of postoperative expectations.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026